Search Results for keywords:"Rockville MD"

The National Institute of Mental Health has announced a closed meeting of the Special Emphasis Panel on February 26, 2021, to review grant applications related to the BRAIN Initiative. This meeting will be held via telephone conference at the National Institutes of Health Neuroscience Center in Rockville, MD. The meeting will be closed to the public because it involves discussions of confidential grant applications and personal information, which, if disclosed, could invade personal privacy or reveal trade secrets. For more details, Rebecca Steiner Garcia, Ph.D., is the Scientific Review Officer coordinating these activities.

The National Institute of Neurological Disorders and Stroke (NINDS) is announcing a series of closed meetings to review and evaluate grant applications. These meetings, held virtually at the National Institutes of Health Neuroscience Center in Rockville, MD, will occur on multiple dates in February and March 2021. The sessions are closed to the public as they may involve discussions on confidential trade secrets and personal information. The meetings are part of the NINDS's activities to assess applications for various research grants in neurological disorders.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 9, 2025, from 12:00 p.m. to 5:00 p.m. This meeting will focus on reviewing and evaluating specific grant applications. It will be closed to the public to protect confidential information, such as trade secrets and personal information, associated with the grants. The meeting will take place at the NIH in Rockville, MD, and will be conducted as a video-assisted session.

The National Institute on Deafness and Other Communication Disorders gave notice of a change in the meeting schedule for their Special Emphasis Panel. Originally set for February 5, 2021, the meeting will now take place on February 17, 2021. The meeting will be held at the National Institutes of Health, Neuroscience Center, in Rockville, MD, but it is closed to the public. This update was published in the Federal Register on January 19, 2021.

The National Institute of Allergy and Infectious Diseases has announced a closed meeting scheduled for January 24, 2025, from 1:00 p.m. to 4:00 p.m. The meeting is closed to the public due to confidential discussions about contract proposals, which may include sensitive commercial information or personal data. This meeting involves the review and evaluation of proposals related to devices and materials-based platforms for delivering broadly neutralizing antibodies. The session will be held in Rockville, MD, but will be video-assisted, and Dr. Samita S. Andreansky will serve as the contact person for the meeting.

The National Institute of Allergy and Infectious Diseases (NIAID) is holding a closed meeting of the Special Emphasis Panel on May 13-14, 2025. This meeting will review and evaluate grant applications for the Engineering Durable HIV Vaccine Protection (ENDURE) initiative. It will be held virtually at the NIH's facilities in Rockville, MD. The meeting is closed to the public to protect confidential trade secrets, commercial property, and personal information associated with the grant applications.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 5, 2025, to evaluate grant applications. The meeting is being closed to the public to protect confidential information like trade secrets and personal privacy. It will take place using video assistance at the National Institutes of Health in Rockville, MD. Dr. Maryam Rohani is the contact person for more details about this scientific review.

The National Institute of Allergy and Infectious Diseases, part of the Health and Human Services Department, is holding a closed meeting on April 24-25, 2025. This meeting, which will occur via video and at their Rockville, MD location, is intended to review and evaluate contract proposals for rapid diagnostic assays for self-monitoring of acute or rebound HIV-1 infection. The discussions will be closed to the public to protect confidential and personal information, as revealing this could breach privacy and commercial rights protections. For further details, contact Vishakha Sharma, Ph.D., the Scientific Review Officer.

The National Institute of Allergy and Infectious Diseases will have a closed meeting on February 3, 2025, from 1:00 p.m. to 3:00 p.m., held via video conference at their Rockville, MD location. The session is closed to the public because it involves discussing confidential contract proposals that contain trade secrets, commercial property, or personal information. The meeting's purpose is to review and evaluate development proposals for medical treatments addressing non-tuberculosis mycobacterial infections. For more details, Dr. Mario Cerritelli serves as the contact person for further inquiries.

The National Institute of Allergy and Infectious Diseases announced a closed meeting scheduled for February 11, 2025. The meeting, which will occur via video at their Rockville, MD location, is for reviewing and evaluating grant applications. It will be closed to the public to protect confidential information and personal privacy. Maryam Feili-Hariri, Ph.D., is the contact person for further information regarding the meeting.